In the amyloid precursor protein/presenilin 1 (APP/PS1) AD model, NLRP3 inflammasome defects would shift microglia toward the M2 phenotype, leading to reduced Aβ deposition (Heneka et al., 2013). Here, APP is linked to Alzheimer disease.